Kathleen L Engel (Kathleen Engel)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Histone Deacetylase

Gene Expression

Top Venues

Science advances

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Clare F Malone, Nathaniel W Mabe, Alexandra B Forman, Gabriela Alexe, Kathleen L Engel, Ying-Jiun C Chen, Melinda Soeung, Silvi Salhotra, Allen Basanthakumar, Bin Liu, Sharon Y R Dent, Kimberly Stegmaier
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science advances 10 (22) (2024)
Clare F Malone, Nathaniel W Mabe, Alexandra B Forman, Gabriela Alexe, Kathleen L Engel, Ying-Jiun C Chen, Melinda Soeung, Silvi Salhotra, Allen Basanthakumar, Bin Liu, Sharon Y R Dent, Kimberly Stegmaier
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science advances 10 (22) (2024)
Clare F Malone, Nathaniel W Mabe, Alexandra B Forman, Gabriela Alexe, Kathleen L Engel, Ying-Jiun C Chen, Melinda Soeung, Silvi Salhotra, Allen Basanthakumar, Bin Liu, Sharon Y R Dent, Kimberly Stegmaier
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science advances 10 (22) (2024)
Clare F Malone, Nathaniel W Mabe, Alexandra B Forman, Gabriela Alexe, Kathleen L Engel, Ying-Jiun C Chen, Melinda Soeung, Silvi Salhotra, Allen Basanthakumar, Bin Liu, Sharon Y R Dent, Kimberly Stegmaier
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science advances 10 (22) (2024)
Clare F Malone, Minjee Kim, Gabriela Alexe, Kathleen L Engel, Alexandra B Forman, Amanda L Robichaud, Amy Saur Conway, Amy Goodale, Ashleigh Meyer, Delan Khalid, Allen Thayakumar, John M Hatcher, Nathanael S Gray, Frederica Piccioni, Kimberly Stegmaier
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors. Cancer research (2022)